Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion

被引:11
|
作者
Byron, Sara A. [1 ]
Hendricks, William P. D. [1 ]
Nagulapally, Abhinav B. [2 ]
Kraveka, Jacqueline M. [3 ]
Ferguson, William S. [4 ]
Brown, Valerie, I [5 ]
Eslin, Don E. [6 ]
Mitchell, Deanna [7 ]
Cornelius, Albert [7 ]
Roberts, William [8 ,9 ]
Isakoff, Michael S. [10 ]
Oesterheld, Javier E. [2 ]
Wada, Randal K. [11 ]
Rawwas, Jawhar [12 ]
Neville, Kathleen [13 ]
Zage, Peter E. [8 ,9 ]
Harrod, Virginia L. [14 ]
Bergendahl, Genevieve [2 ]
VanSickle, Elizabeth [7 ]
Dykema, Karl [2 ]
Bond, Jeffrey [7 ]
Chou, Hsien-Chao [15 ]
Wei, Jun S. [15 ]
Wen, Xinyu [15 ,16 ]
Reardon, Hue, V [17 ]
Roos, Alison [1 ]
Nasser, Sara [1 ]
Izatt, Tyler [1 ]
Enriquez, Daniel [1 ]
Hegde, Apurva M. [1 ]
Cisneros, Faith [1 ]
Christofferson, Austin [1 ]
Turner, Bryce [1 ]
Szelinger, Szabolcs [1 ,18 ]
Keats, Jonathan J. [1 ]
Halperin, Rebecca F. [1 ]
Khan, Javed [15 ]
Sholler, Giselle L. Saulnier [2 ]
Trent, Jeffrey M. [1 ]
机构
[1] Translat Genom Res Inst TGen, Phoenix, AZ USA
[2] Levine Childrens Hosp, Charlotte, NC USA
[3] Med Univ South Carolina, Charleston, SC 29425 USA
[4] St Louis Univ, Sch Med, St Louis, MO USA
[5] Penn State Milton S Hershey Med Ctr, Penn State Hlth Childrens Hosp, Hershey, PA USA
[6] St Josephs Childrens Hosp, Tampa, FL USA
[7] Helen DeVos Childrens Hosp, Grand Rapids, MI USA
[8] Rady Childrens Hosp, Peckham Ctr Canc & Blood Disorders, San Diego, CA USA
[9] Univ Calif San Diego, Dept Pediat, Div Hematol Oncol, La Jolla, CA 92093 USA
[10] Connecticut Childrens Med Ctr, Ctr Canc & Blood Disorders, Hartford, CT USA
[11] Kapiolani Med Ctr Women & Children, Honolulu, HI USA
[12] Childrens Hosp & Clin Minnesota, Minneapolis, MN USA
[13] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
[14] Dell Childrens Med Ctr, Austin, TX USA
[15] NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[16] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Frederick, MD USA
[17] Frederick Natl Lab Canc Res, Biomed Informat & Data Sci, Adv Biomed Computat Sci, Frederick, MD USA
[18] Ashion Analyt, Phoenix, AZ USA
关键词
EVOLUTIONARY HISTORY; GENE-EXPRESSION; MUTATIONS; CANCER; SIGNATURES; THERAPY; CHILDREN; GAIN;
D O I
10.1158/0008-5472.CAN-21-1033
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Children with treatment-refractory or relapsed (R/R) tumors face poor prognoses. As the genomic underpinnings driving R/R disease are not well defined, we describe here the genomic and transcriptomic landscapes of R/R solid tumors from 202 patients enrolled in Beat Childhood Cancer Consortium clinical trials. Tumor mutational burden (TMB) was elevated relative to untreated tumors at diagnosis, with one-third of tumors classified as having a pediatric high TMB. Prior chemotherapy exposure influenced the mutational landscape of these R/R tumors, with more than 40% of tumors demonstrating mutational signatures associated with platinum or temozolomide chemotherapy and two tumors showing treatmentassociated hypermutation. Immunogenomic profiling found a heterogenous pattern of neoantigen and MHC class I expression and a general absence of immune infiltration. Transcriptional analysis and functional gene set enrichment analysis identified crosspathology clusters associated with development, immune signaling, and cellular signaling pathways. While the landscapes of these R/R tumors reflected those of their corresponding untreated tumors at diagnosis, important exceptions were observed, suggestive of tumor evolution, treatment resistance mechanisms, and mutagenic etiologies of treatment. Significance: Tumor heterogeneity, chemotherapy exposure, and tumor evolution contribute to the molecular profiles and increased mutational burden that occur in treatment-refractory and relapsed childhood solid tumors. _2021 American Association for Cancer Research. © 2021 American Association for Cancer Research Inc.. All rights reserved.
引用
收藏
页码:5818 / 5832
页数:15
相关论文
共 2 条
  • [1] Analysis of the genomic landscape of yolk sac tumors reveals mechanisms of evolution and chemoresistance
    Zong, Xuan
    Zhang, Ying
    Peng, Xinxin
    Cao, Dongyan
    Yu, Mei
    Wang, Jinhui
    Li, Hongyue
    Guo, Xuejiao
    Liang, Han
    Yang, Jiaxin
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [2] Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity
    Yang, S. Y. Cindy
    Lien, Scott C.
    Wang, Ben X.
    Clouthier, Derek L.
    Hanna, Youstina
    Cirlan, Iulia
    Zhu, Kelsey
    Bruce, Jeffrey P.
    El Ghamrasni, Samah
    Iafolla, Marco A. J.
    Oliva, Marc
    Hansen, Aaron R.
    Spreafico, Anna
    Bedard, Philippe L.
    Lheureux, Stephanie
    Razak, Albiruni
    Speers, Vanessa
    Berman, Hal K.
    Aleshin, Alexey
    Haibe-Kains, Benjamin
    Brooks, David G.
    McGaha, Tracy L.
    Butler, Marcus O.
    Bratman, Scott, V
    Ohashi, Pamela S.
    Siu, Lillian L.
    Pugh, Trevor J.
    NATURE COMMUNICATIONS, 2021, 12 (01)